NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Posted on November 23, 2022July 10, 2023 by fraziermwd
VectivBio Announces Pricing of $125 Million Underwritten Offering of Ordinary Shares Posted on October 13, 2022July 10, 2023 by fraziermwd
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock Posted on October 4, 2022July 10, 2023 by fraziermwd
Sudo Biosciences Raises $37M Series A Financing to Advance Precision TYK2 Therapeutics Posted on September 28, 2022July 10, 2023 by fraziermwd
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock Posted on September 19, 2022July 10, 2023 by fraziermwd
FDA Approves Arcutis’ ZORYVE™ (Roflumilast) Cream 0.3% For the Treatment of Plaque Psoriasis in Individuals Age 12 and Older Posted on July 29, 2022July 10, 2023 by fraziermwd
Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners Posted on May 9, 2022July 10, 2023 by fraziermwd
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults Posted on May 3, 2022July 10, 2023 by fraziermwd
